As of Apr 29
| -1.07 / -1.48%|
The 4 analysts offering 12-month price forecasts for West Pharmaceutical Services Inc have a median target of 67.00, with a high estimate of 71.00 and a low estimate of 59.00. The median estimate represents a -5.90% decrease from the last price of 71.20.
The current consensus among 5 polled investment analysts is to Buy stock in West Pharmaceutical Services Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.